Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nova Mentis Life Science Corp. C.LIB

Nova Mentis Life Science Corp is a Canadian-based company focused on building and supporting a diversified portfolio of health and wellness businesses. Through its subsidiary, the company is focused on exploring the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes and providing a Health Canada Standard Licensed facility focused on the cultivation of AAAA premium, small batch, terpene rich dominant cultivars cured to perfection.


CSE:LIB - Post by User

Comment by Iseneschalon Jul 13, 2019 9:22am
115 Views
Post# 29916606

RE:Heads up !

RE:Heads up !
Iseneschal wrote:
Do some research on PRIM.

Looks like they're going to switch business to me.
Mining to pot. Cheap to. LoL


Just wondering if anyone followed up on my 04/12/19 post re: PRIM
Crystalized profits just before the recent halt on news . Cha Ching !!!

I also have to mention...........

Liberty Leaf grants options to buy 3.55 million shares

2019-07-12 23:10 PT - News Release

Mr. Will Rascan reports

LIBERTY LEAF GRANTS INCENTIVE STOCK OPTIONS

Liberty Leaf Holdings Ltd. has issued an aggregate of 3.55 million incentive stock options to officers, directors, advisory board members and consultants of the company, exercisable at 10.5 cents per share. A total of 2.3 million are valid for a period of two years from the date of grant, and a total of 1.25 million are valid for a period of one year from the date of grant. The options have been granted under and are governed by the terms of the company's incentive stock option plan. Options issued to directors and officers will be subject to a four-month-and-one-day hold period.



<< Previous
Bullboard Posts
Next >>